VOYA Investment Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.06M | Buy |
33,401
+6,679
| +25% | +$211K | ﹤0.01% | 1557 |
|
2025
Q1 | $887K | Buy |
26,722
+3,851
| +17% | +$128K | ﹤0.01% | 1623 |
|
2024
Q4 | $787K | Buy |
22,871
+144
| +0.6% | +$4.96K | ﹤0.01% | 1721 |
|
2024
Q3 | $909K | Sell |
22,727
-3,129
| -12% | -$125K | ﹤0.01% | 1701 |
|
2024
Q2 | $780K | Sell |
25,856
-543
| -2% | -$16.4K | ﹤0.01% | 1760 |
|
2024
Q1 | $886K | Buy |
26,399
+1,266
| +5% | +$42.5K | ﹤0.01% | 1693 |
|
2023
Q4 | $812K | Buy |
25,133
+4,254
| +20% | +$137K | ﹤0.01% | 1796 |
|
2023
Q3 | $684K | Buy |
20,879
+188
| +0.9% | +$6.16K | ﹤0.01% | 1870 |
|
2023
Q2 | $728K | Buy |
20,691
+2,889
| +16% | +$102K | ﹤0.01% | 1867 |
|
2023
Q1 | $581K | Sell |
17,802
-118
| -0.7% | -$3.85K | ﹤0.01% | 1965 |
|
2022
Q4 | $987K | Hold |
17,920
| – | – | ﹤0.01% | 1650 |
|
2022
Q3 | $794K | Buy |
17,920
+2,910
| +19% | +$129K | ﹤0.01% | 1753 |
|
2022
Q2 | $732K | Buy |
15,010
+5,791
| +63% | +$282K | ﹤0.01% | 1603 |
|
2022
Q1 | $449K | Buy |
9,219
+401
| +5% | +$19.5K | ﹤0.01% | 1981 |
|
2021
Q4 | $376K | Sell |
8,818
-43
| -0.5% | -$1.83K | ﹤0.01% | 2180 |
|
2021
Q3 | $340K | Hold |
8,861
| – | – | ﹤0.01% | 2274 |
|
2021
Q2 | $250K | Buy |
+8,861
| New | +$250K | ﹤0.01% | 2471 |
|